• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.3627 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.3627
Bid (Size) 0.3500 (200)
Ask (Size) 0.3735 (600)
Prev. Close 0.3627
Today's Range 0.3627 - 0.3627
52wk Range 0.2805 - 1.320
Shares Outstanding 34,919,920
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers in Friday's after hours session ↗
April 24, 2026
Via Chartmill
News headline image
Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products
April 21, 2026
Via ACCESS Newswire

Performance

YTD
-29.6%
-29.6%
1 Month
+11.2%
+11.2%
3 Month
-28.3%
-28.3%
6 Month
-60.4%
-60.4%
1 Year
-12.8%
-12.8%

More News

Read More
News headline image
Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio
April 20, 2026
Via ACCESS Newswire
News headline image
Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health
April 17, 2026
Via ACCESS Newswire
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
April 16, 2026
Via Chartmill
News headline image
Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%
April 16, 2026
Via ACCESS Newswire
News headline image
Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into
April 15, 2026
Via ACCESS Newswire
News headline image
Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units
April 13, 2026
Via ACCESS Newswire
News headline image
Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months
April 10, 2026
Via ACCESS Newswire
News headline image
Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets
April 01, 2026
Via ACCESS Newswire
News headline image
Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue
March 19, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000
March 11, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000
March 10, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
February 24, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
February 19, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer
February 18, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK’s Largest Retailer
February 18, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
February 17, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies
February 11, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue
January 20, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research
January 14, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
January 05, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
December 24, 2025
Via ACCESS Newswire
News headline image
Cosmos Health is Forcing the Market to Reframe the Conversation
December 19, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
December 03, 2025
From Cosmos Health Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Cosmos Health Inc. - Common Stock publicly traded?
Yes, Cosmos Health Inc. - Common Stock is publicly traded.
What exchange does Cosmos Health Inc. - Common Stock trade on?
Cosmos Health Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cosmos Health Inc. - Common Stock?
The ticker symbol for Cosmos Health Inc. - Common Stock is COSM on the Nasdaq Stock Market
What is the current price of Cosmos Health Inc. - Common Stock?
The current price of Cosmos Health Inc. - Common Stock is 0.3627
When was Cosmos Health Inc. - Common Stock last traded?
The last trade of Cosmos Health Inc. - Common Stock was at 04/27/26 04:00 PM ET
What is the market capitalization of Cosmos Health Inc. - Common Stock?
The market capitalization of Cosmos Health Inc. - Common Stock is 12.67M
How many shares of Cosmos Health Inc. - Common Stock are outstanding?
Cosmos Health Inc. - Common Stock has 13M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap